(IN BRIEF) Sanofi has completed the acquisition of DR-0201 from Dren Bio, now renamed SAR448501, to enhance its immunology pipeline. This bispecific myeloid cell engager, which has shown promising results in B-cell depletion, may offer potential breakthroughs in autoimmune diseases, … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged acquisition, antibody therapeutics, autoimmune diseases, B cell depletion, biopharmaceuticals, bispecific myeloid cell engager, clinical-stage, DR-0201, Dren Bio, immunology, lupus, partnership, phagocytosis, Sanofi, SAR448501, therapeutics
(IN BRIEF) Researchers from the University of Southampton will join the Breast Walk Ever charity event on 8 June 2025 to support Against Breast Cancer and raise funds for vital research into secondary breast cancer. ABC-funded PhD student Grace Hayes … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Media, News, Science, Society, Technology, United Kingdom
Tagged ABC events, Against Breast Cancer, bone metastasis, Breast Walk Ever, Cancer Detection, cancer research, charity event, Deborah Parnell, fundraising, fundraising event, Grace Hayes, Hursley, immunology, immunotherapy, miONCO test, PhD student research, Richard Martin, secondary breast cancer, Southampton researchers, University of Southampton, Winchester
(IN BRIEF) GSK and the University of Cambridge have announced a £50 million, five-year collaboration called the Cambridge-GSK Translational Immunology Collaboration (CG-TIC) to accelerate research and development in kidney and respiratory diseases. The initiative combines GSK’s expertise in immunology and … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged AI, Cambridge University, Cambridge-GSK Translational Immunology Collaboration (CG-TIC), GSK, immunology, investment, Kidney and Respiratory Diseases, Nicolas Wisniacki, partnership, Peter Kyle, Professor David Thomas, safety, sustainability, Tony Wood
(IN BRIEF) AstraZeneca has entered into a collaboration and investment agreement with biotech firm Cellectis to fast-track the development of cutting-edge therapeutics in areas such as oncology, immunology, and rare diseases. This partnership will leverage Cellectis’ gene editing technologies and … Read the full press release
Posted in Business, Education, Environment, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Adrian Kemp, André Choulika, AstraZeneca, Cellectis, gene therapy, immunology, Marc Dunoyer, oncology, partnership, rare diseases, sustainability
(IN BRIEF) Merck, a prominent science and technology company, has announced strategic drug discovery collaborations with AI technology firms BenevolentAI and Exscientia. These partnerships aim to leverage AI-driven design and discovery capabilities to advance research efforts in key therapeutic areas, … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AI, AI-Driven Drug, BenevolentAI, Danny Bar-Zohar, data, Exscientia, immunology, Merck, Neurology, oncology, partnership, science
(IN BRIEF) H. Lundbeck A/S has announced the initiation of CEO succession, with Deborah Dunsire choosing to retire from her role as President and CEO. Charl van Zyl has been appointed as the new President and CEO, and Dunsire will … Read the full press release
Posted in Business, Denmark, Healthcare, Management, Pharma & Biotech
Tagged appointment, biopharma, Board of Directors, CEO, Charl van Zyl, CNS, Deborah Dunsire, Eli Lilly, H. Lundbeck A/S, immunology, Lars Rasmussen, Lundbeck, Neurology, Novartis
(PRESS RELEASE) SANOFI, 29-Mar-2022 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused on human health, has announced an exclusive worldwide collaboration agreement signed with IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and … Read the full press release
(PRESS RELEASE) PARIS, 29-Mar-2022 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused on human health, has announced that the company will provide an update on its Immunology strategy at its Immunology Investor Event, which is taking place … Read the full press release
Posted in France, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged Bill Sibold, chronic inflammatory diseases, Chronic obstructive pulmonary disease, COPD, dupilumab, Dupixent, immunology, Immunology Investor Event, John Reed, NANOBODY®, Regeneron Pharmaceuticals, Sanofi, synthetic cytokines, Tailored Covalency®, type 2 inflammation
Tony Wood to assume full accountability for GSK R&D in August 2022 Hal Barron to transition in August 2022 from CSO to a GSK Non-Executive Director with additional responsibilities to support R&D (PRESS RELEASE) LONDON, 19-Jan-2022 — /EuropaWire/ — GlaxoSmithKline … Read the full press release
Posted in Artificial Intelligence (AI), Healthcare, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Academy of Medical Sciences, Adrestia, Altius Institute, Altos Labs, appointment, artificial-intelligence, biotechnology, Blenrep, Board of the Rosalind Franklin Institute, Cabenuva, Chief Scientific Officer, CSO, Dr. Hal Barron, Emma Walmsley, Genome Research, genomics, GlaxoSmithKline plc, GSK, immunology, Imperial College, infectious disease, Jemperli, Machine Learning, medicines, Nucala®, oncology, Pfizer, R&D, research and development, Royal Society of Biology, Royal Society of Chemistry, Tony Wood, UK National Genomics Board, University of Newcastle, Xevudy
(PRESS RELEASE) STOCKHOLM, 2-Sep-2021 — /EuropaWire/ — Investor AB (STO: INVE-B), a Swedish investment and holding company founded in 1916, has announced its support for the Agnafit Bidco¹’s bid for Sobi (Swedish Orphan Biovitrum AB). The company has undertaken to … Read the full press release
Posted in Business, Healthcare, Investment, Management, News, Pharma & Biotech, Science, Sweden, Technology
Tagged acquisitions, Advent International, Advent International Corporation, Agnafit Bidco, Aurora Investments Pte Ltd, Biovitrum, GIC Pte Ltd., GIC Special Investments Pte Ltd, Healthcare, hematology, hemophilia, immunology, Investor AB, Johan Forssell, public offer, shares, Sobi, Swedish Orphan Biovitrum AB, Swedish Orphan International
SOUTHAMPTON, 02-Feb-2018 — /EuropaWire/ — The University of Southampton is delighted to announce it has reached its £25m target to fund the UK’s first dedicated centre for cancer immunology research. For decades, Southampton scientists have made a number of advances … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged cancer immunology research, Centre for Cancer Immunology, immunology, Patricia Marriott, Professor Sir Christopher Snowden, Professor Tim Elliott, The University of Southampton, University Hospital Southampton
Not for audiences in the US and Canada LONDON, 26-8-2015 — /EuropaWire/ — This week, epgonline.org, the website for healthcare professionals, welcomes the launch of a free symptomatic asthma Continuing Medical Education (CME) activity, available at epgonline.org/symptomatic-asthma/cme/. Accredited by the … Read the full press release
We are supporting research and development into innovative drug treatments in Hungary 7-5-2013 — /europawire.eu/ — For well over 100 years, Hungarian pharmaceutical company Gedeon Richter has been working to improve their clients’ health and quality of life. It has stepped … Read the full press release
Posted in Banks, Business, European Union, Financial, Government, Healthcare, Hungary, Investment, Pharma & Biotech, Science
Tagged Anton Rop, biosimilars, biotechnology, EIB, equity investment, Gedeon Richter, guarantees, immunology, INNOVATION, loans, pharmaceutical company, R&D operation, Risk Sharing Finance Facility, treat cancer, Zsolt Szombathelyi
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?